Anzeige
Mehr »
Login
Montag, 27.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
US-Präsident setzt auf die Solana Blockchain! Diese Krypto-Perle profitiert enorm!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Business Review

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
12.11.24Lakeside Holding agrees to acquires Hupan Pharmaceutical
11.11.24Alteogen and Daiichi Sankyo sign license deal for ADC development
08.11.24New England Biolabs opens new manufacturing facility in UK
07.11.24Plus Therapeutics partners with SpectronRx for CNS therapy development
06.11.24Insignis Therapeutics' IN-001 clinical programme receives positive FDA response
05.11.24Ring Therapeutics signs partnerships to advance R&D in biomedical sciences
04.11.24NEOGAP and NorthX Biologics partner for cancer cell therapy production
01.11.24Electra Therapeutics secures FDA ODD status for HLH treatment
31.10.24Shanghai Henlius Biotech, Organon announce FDA acceptance of BLA for HLX14
30.10.24FDA expands approval for Shorla's JYLAMVO to paediatric patients
29.10.24Kivu Bioscience secures $92m in Series A funding for ADC development
28.10.24FDA grants IND clearance for RiboX's RXRG001
25.10.24Lyell signs agreement to acquire ImmPACT Bio
24.10.24FDA issues CRL to PharmaTher's ketamine ANDA
23.10.24TerSera acquires global rights to MacroGenics' MARGENZA for breast cancer treatment
22.10.24Samsung Biologics signs $1.24bn manufacturing deal with Asian pharma company
21.10.24Novartis gets positive CHMP opinion for Kisqali in early breast cancer
18.10.24AscellaHealth acquires specialty pharmaceutical wholesaler CHAPPER healthcare
17.10.24Astria Therapeutics' navenibart gains orphan medicinal status from EC
16.10.24RTI partners with Codetta Bio to boost healthcare innovation
15.10.24Samsung Biologics launches biopharmaceutical platform S-HiCon
14.10.24Stealth's elamipretide gains FDA advisory committee support for Barth syndrome
11.10.24Volixibat gains FDA breakthrough therapy designation
10.10.24insitro collaborates with Lilly on metabolic disease treatments
09.10.24PsychoGenics secures NIH contract to identify new pain therapeutics